Table 1 The combined evaluation response approach
Type | Tumor largest diameter | Intensity of enhancement |
|---|---|---|
• Progressive disease | Increase | +/− change in the intensity |
• Stable disease | No change in size | No change |
• Poor response | Up to 30% decrease | Decrease in intensity |
• Moderate response | 30–60% decrease | Decrease in intensity |
• Marked response | > 60% decrease | Residual faint enhancement |
• Complete Response | No residual lesion seen | |